Research Article
Functional Inflammatory Genotypes in Ischemic Stroke: Could We Use Them to Predict Age of Onset and Long-Term Outcome?
Table 3
Statistics of the disease-free survival analysis.
| | Disease-free survival analysis | | Median (SE) | KM log rank | Cox regression* | | | Odds ratio (95% CI) |
| TNF-α-308G>A | | | | GA | 65 (4.93) | .70 | Referent | GG | 68 (1.97) | 0.74 (0.49–1.12) | IL6-174G>C | | | | GG | 65 (2.01) | .86 | Referent | GC/CC | 69 (1.66) | 0.70 (0.51–1.22) | IL12B 1188A>C | | | | AA | 67 (2.00) | .62 | Referent | AC/CC | 70 (2.58) | 1.02 (0.72–1.44) | IL4-589C>T | | | | CC | 67 (2.08) | .91 | Referent | CT | 68 (4.10) | 1.07 (068–1.70) | IL10-1082G>A | | | | GA/AA | 68 (2.09) | .55 | Referent | GG | 65 (6.06) | 1.43 (0.92–2.22) |
|
|
SE: standard error, KM: Kaplan-Mayer, CI: confidence intervals.
*Adjusted for sex, hypertension, diabetes, hyperlipidemia, atrial fibrillation, ischemic heart disease, and smoking.
|